The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar
Status:
Completed
Trial end date:
2019-04-09
Target enrollment:
Participant gender:
Summary
This study aims to:
1. Determine the prevalence of Helicobacter infection in Myanmar (this would be the largest
ever series in the country)
2. Determine the clinical and epidemiological associations of Helicobacter infection in
Myanmar
3. Determine the utility of stool antigen testing to diagnose the infection and confirm
eradication
4. Compare the relative efficacies of concomitant and sequential therapy
5. Determine the relative efficacies of first, second and third line therapies in Myanmar
in 2018